Professor Melanie Calvert awarded Academy of Medical Sciences Fellowship

Professor Melanie Calvert, co-lead of our Birmingham BRC Patient-reported Outcomes research theme, has been recognised for her contributions to advancing medical sciences and translating developments into benefits for patients and the wider public, as she has been announced to be among the newest Fellows of the Academy of Medical Sciences. A formal admission will take place at a ceremony on Wednesday 9 July 2025.

The Academy aims to create an open and progressive research sector that improves health for everyone, with the elected Fellows offering a breadth of knowledge across clinical and non-clinical disciplines, such as infectious disease and stem cell biology, to veterinary medicine and dementia research.

The Fellowship is known to be a prestigious award; Fellows are selected for their outstanding research, or service to medical science through raising public appreciation or understanding, which Professors Calvert has been recognised for across her area of specialty.

“It is important recognition, not only of my work, but colleagues at the University of Birmingham, our international collaborators and wonderful patient partners.”

Professor Melanie Calvert

Professor Melanie Calvert is an NIHR Senior Investigator and Professor of Outcomes Methodology at the University of Birmingham, as well as the Director of the Centre for Patient Reported Outcomes Research. Professor Calvert’s focus on patient-reported outcomes has most recently supported work with Innovate UK and the Catapult network to establish a new network for effective regulation of advanced therapies in the UK.

In response to receiving the Fellowship, she said: “It’s an honour to be elected to the Fellowship of the Academy of Medical Sciences. It is important recognition, not only of my work, but colleagues at the University of Birmingham, our international collaborators and wonderful patient partners. I look forward to providing senior leadership within the Academy and building capacity for patient centred research.”